0001415889-24-017526.txt : 20240618 0001415889-24-017526.hdr.sgml : 20240618 20240618210118 ACCESSION NUMBER: 0001415889-24-017526 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240613 FILED AS OF DATE: 20240618 DATE AS OF CHANGE: 20240618 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Boylan James P CENTRAL INDEX KEY: 0001953094 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39580 FILM NUMBER: 241053779 MAIL ADDRESS: STREET 1: C/O ENAVATE SCIENCES STREET 2: 2884 SAND HILL RD., STE 100 CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Immunome Inc. CENTRAL INDEX KEY: 0001472012 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 770694340 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 18702 N. CREEK PARKWAY STREET 2: SUITE 100 CITY: BOTHELL STATE: WA ZIP: 98011 BUSINESS PHONE: 610-321-3700 MAIL ADDRESS: STREET 1: 18702 N. CREEK PARKWAY STREET 2: SUITE 100 CITY: BOTHELL STATE: WA ZIP: 98011 4 1 form4-06192024_010614.xml X0508 4 2024-06-13 0001472012 Immunome Inc. IMNM 0001953094 Boylan James P C/O IMMUNOME, INC. 18702 N. CREEK PARKWAY, SUITE 100 BOTHELL WA 98011 true false false false 0 Stock option (right to buy) 16.04 2024-06-13 4 A 0 11333 0 A 2034-06-12 Common Stock 11333 11333 D Mr. Boylan has agreed to receive and hold for the benefit of Enavate Sciences, LP, any securities granted to him for his service as a director on the Company's board of directors. As such, Mr. Boylan disclaims beneficial ownership of, and all right, title and interest in, the reported securities. The options vest in 4 quarterly installments, commencing from June 13, 2024 until the one year anniversary thereafter, occurring on the same day of each succeeding fiscal quarter, subject to continued service with the Company on each respective vesting date. /s/ Sandra Stoneman, Attorney-in-Fact 2024-06-18